The opinions of the CPC Central Committee and the State Council on deepening the reform of medical and health system is a balanced, comprehensive and all-round medical reform plan, which puts forward many effective methods to alleviate the problem of "difficult to see doctors and expensive medical treatment" of the masses, and has formed a broad consensus on the establishment of basic drug catalogue, and the new medical reform has made a great deal of difference to the pharmaceutical industry, Especially in pharmaceutical enterprises, people in the industry generally believe that; What are the impacts.
1、 The sales scale of low price generic medicine will increase
The opinions suggest that basic drugs should be provided and used by basic medical institutions such as urban community health service center (station), township health hospital and village health room. Other medical institutions should also take basic drugs as the first drug and determine the use proportion. And it is stipulated that all basic drugs are included in the reimbursement catalogue of basic medical insurance system drugs, and the reimbursement ratio is significantly higher than that of non basic drugs. At present, to achieve full coverage of medical security, it must be low level. Whether from the expansion of the number of basic medical institutions or the composition of basic drugs, the sales of low-cost generic drugs will increase.
2、 The demand for alternative high price drugs is reduced
The new prescription management measures implemented in 2007 require doctors to use generic names of drugs, the names of patented drugs and compound preparations, but not the names of commodities. This makes the high price drugs of some joint ventures replaced by the corresponding domestic low-cost drugs. After the medical reform, we will actively explore the establishment of negotiation mechanism between medical insurance agencies, medical institutions and drug suppliers, give full play to the restriction of medical services and drug costs by medical security institutions, and improve payment system, actively explore the ways of paying by head, paying by disease, prepaying the total amount, etc. These measures will inhibit the use of high price drugs to a certain extent.
3、 Irreplaceable high price drugs demand is unchanged
The opinions encourage enterprises and individuals to solve the needs beyond basic medical insurance by participating in commercial insurance and various forms of supplementary insurance. In the early stage of medical reform, the basic medical security is low level, so there will be a large market for non basic drugs, and there is still a large space for high-end generic drugs to replace imported drugs. The price of the imitated drugs is from low price system, which will inhibit the low-level repeated construction. According to this pricing method, combined with other restrictive measures, it is expected that each generic enterprise without patent drugs will be controlled in a small number of households, which provides a system guarantee for those enterprises with the first imitation ability to obtain higher profits.
4、 The demand of traditional Chinese medicine is very guaranteed
The opinion puts forward that the function of traditional Chinese medicine should be fully played in the basic principles to be followed in medical reform, and to explore and establish a basic medical and health system in line with the national conditions. It also proposes to strengthen the construction of clinical research base and hospital of traditional Chinese medicine, organize and carry out joint efforts to tackle difficult diseases of TCM, and vigorously promote the appropriate technology of TCM in medical and health institutions. With the gradual implementation of relevant measures, TCM is expected to find a foothold in the grass-roots level, which is of great significance to the development of traditional Chinese medicine and the expansion of the sales of traditional Chinese medicine.
